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Letter to the Editor

The usual course of thorax CT findings of COVID-19 infection and
when to perform control thorax CT scan
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Abstract: COVID-19 infection, a highly contagious disease caused by the SARS-CoV virus, and the World Health Organization declared
this increasingly spreading disease as a global public health emergency (pandemic). In the diagnosis of COVID-19, the polymerase
chain reaction (RT-PCR) is considered as the reference standard test. In the early stages, thorax CT findings could be present even
before the onset of symptoms, thorax CT has quite high sensitivity in COVID-19 patients with false negative RT-PCR results, and it has
a great importance not only in diagnosis but also in follow up. We think that it might be beneficial for our radiologist colleagues in the
early diagnosis of the imaging features of this disease, by sharing the experiences we have gained by evaluating the typical and relatively
atypical CT findings regarding the natural course of the tomographic findings of COVID-19 and when to control CT.
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1. Introduction
COVID-19 infection, a highly contagious disease caused
by the SARS-CoV virus, was first reported in Wuhan,
China, and the World Health Organization declared
this increasingly spreading disease as a global public
health emergency (pandemic) on January 30, 2020 [1,2].
The disease is transmitted by inhalation or contact with
infected droplets, and the incubation period ranges from
2–14 days. Symptoms are usually fever, cough, sore throat,
shortness of breath. Disease findings are mild in the
most of cases who are asymptomatic; however, in some
patients (usually the elderly and those with comorbidity),
it may progress to pneumonia, acute respiratory distress
syndrome, and multiple organ dysfunction. Case mortality
rate is estimated to vary between 2%–3% [3].
In the diagnosis of COVID-19, the polymerase chain
reaction (RT-PCR) is considered as the reference standard
test. It has been reported that SARS-CoV-2 uses angiotensin
converting enzyme-2 (ACE-2) as a cell receptor in humans
and to cause pulmonary interstitial damage first and then
parenchymal changes [4,5].
In Turkey, the first case was reported on 11th March,
2020 and the number of cases has increased rapidly as
expected since that date, as also in our province (Sakarya).
In the last 20 days until 05th April, 2020, approximately
5000 thorax computed tomography (CT) images were

taken with suspicion of COVID-19 in our province and
3000 PCR tests were done and thorax CT was used as a
diagnostic tool in the days when PCR test could not be
performed. In this period, we think that it might be
beneficial for our radiologist colleagues in the early
diagnosis of the imaging features of this disease, which
has become a major public health problem, by sharing the
experiences we have gained by evaluating the typical and
relatively atypical CT findings regarding the usual course
of the tomographic findings of COVID-19 and when to
control CT.
2. The usual course of thorax CT findings of COVID-19
infection
Recent studies have shown that; though the diagnostic
value of chest radiographs is low in the early stages, thorax
CT findings could be present even before the onset of
symptoms, thorax CT has quite high sensitivity (98%) in
COVID-19 patients with false negative RT-PCR results,
and it has a great importance in early diagnosis [6,7].
In the early period of the disease (days 1–5), the
bilateral distribution of subplevral or peribroncovascular,
multifocal, patchy or segmental, consolidated or
unconsolidated ground-glass opacities in the peripheral
and posterior sections of the lower lobes of the lungs
constitute the basic CT findings of our COVID-19

* Correspondence: dryasemingunduz@yahoo.com

684

This work is licensed under a Creative Commons Attribution 4.0 International License.

GÜNDÜZ et al. / Turk J Med Sci
cases. They were compatible with most of the previous
radiological studies [4,5,7]. Ground glass opacification
could be seen alone or together with inter/intralobular
septal thickening (the crazy paving pattern).
Between the 5th and 10th days, thorax CT findings
increased gradually in the first weeks during the usual
course of the disease, and ground glass opacities in the early
period started to consolidate. The ground glass opacities
can be seen alone or together with inter/intralobular septal
thickening, the crazy paving pattern, and rarely the halo
sign has also been detected.
Between the 10th and 15th days, the peak period of
the disease, the findings in the midterm increased further
and proceeded to central zones and started to show a
tendency to merge and rarely the reverse halo sign and air
bronchogram patterns were also observed in this period.
Between the 15th and 28th days, CT findings began to
gradually decrease and these findings resolved completely
without any sequelae or leaving sequelae changes such as
focal ground glass opacities and reticular condensations.
2.1. When to perform control thorax CT scan
However, in every period; pleural effusion, pericardial
effusion, lymphadenopathy, the crazy paving pattern,
consolidated areas more distributed and progressed to the
upper lobes, cavitation and halo findings were significant
in terms of true progression and poor prognosis if the
patient was clinically worsened. If these findings occur,
regardless of the period of the patient, thorax CT scan
should be repeated.
During all of these periods, our patients may be
symptomatic or asymptomatic in the first or middle period
of the disease. Therefore, thorax CT findings with massive
progression may be observed in patients independently
regarding the clinical findings. An important point we
would like to mention here is that CT findings regress
after a certain period of progression in the course of the
disease. In other words, clinicians may see the progressed
radiological findings if they obtain control PA chest X-ray
leading to ordering control thorax CT considering falsely
that there is a clinical progress. In fact, the increase of
radiological findings appears as a usual progress in the
course of the disease. The important point here is the
patient’s clinic. If the patient is clinically well, radiologist
must state that the radiological progress in PA chest X-ray
is the usual course of the disease, and thorax CT should
not be performed again unless there are signs of poor
prognosis. Otherwise, both the patient may be exposed

to unnecessary radiation, and the findings of radiological
progress can be perceived as a real progression, and the
patient may be given more aggressive treatments and
perhaps unnecessary intubation.
As a matter of fact, the oxygen saturations of 2
nonintubated patients in our hospital were about 85–90.
There were signs of progression on the chest X-rays.
However, the clinics of patients (mild to moderate
respiratory distress) did not deteriorate. Therefore, the
nonintubated patients state that radiological progression
would not mean clinical progression. One of the
patients who had a stable follow-up for about a week
had a radiological and clinical improvement during this
period. The patient is still hospitalized in our hospital
and his clinics (and oxygen saturations are between 95%–
99%) continue to improve. The other patient who was
clinically well and PCR test negative while radiologically
progressed was discharged with stable condition after
being followed up for a while since there were no signs
of clinical deterioration. The clinic of the patient who was
under quarantine at home has improved with the routine
controls.
In this context, we would like to remind that intubation
is a risk of mortality, even in normal patients, and we
would like to state that intubations performed because
of the progress of radiological findings in patients with
COVID-19 while the clinic is in good condition may cause
loss of patients. Even if the patient’s saturation decreases
down to 85%–90% and radiological findings progress
while clinically well, our experience is that there is better
chance for recovery in the patients who can tolerate
without intubation for 1 week.
3. Conclusion
The course of thorax CT findings in COVID-19 infection
may be particularly different in each patient and each
period. Thorax CT is a very sensitive diagnostic method
that makes an important contribution to both diagnosis
and determining the course of the disease in eligible
patients. We suggest that if the patient’s clinic is stable
and in good condition or there are no additional signs of
worsening despite radiological findings, we recommend
not to repeatedly scan the patient with CT as well as to
avoid unnecessary medical or interventional procedures.
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